Abstract
An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.
| Original language | Undefined/Unknown |
|---|---|
| State | Published - Apr 22 2020 |
Publication series
| Name | Articles, Abstracts, and Reports |
|---|
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver